Interphex2006: New pharma products include sensor for CIP analysis
Rosemount Analytical introduced its new toroidal conductivity sensor for CIP (clean-in-place) liquid analysis in the pharmaceutical industry at Interphex2006 in New York last week.
New York, NY; Irvine, CA —New Rosemount Analytical toroidal conductivity sensor for CIP (clean-in-place) liquid analysis in the pharmaceutical industry debuted last week at Interphex2006 . Demonstrations of the device were held at the Emerson life science solutions exhibit at the Javits Convention Center in New York City, Mar. 21-23, 2006.
Rosemount Analytical Model 225-08 consists of a pair of wire-wound metal toroids overmolded with a special grade of PEEK (polyetheretherketone). It is suited for use in concentrations of acids, alkalis, and rinse waters often found in pharmaceutical cleaning processes. Raw materials are tested and certified based on USP Class VI biological reactivity tests. Material traceability for the wetted materials of the sensor helps streamline the validation process in pharmaceutical applications. Robust device is said to be “designed to withstand the rigors of clean-in-place”.
Sensor can be integrated into the DeltaV digital automation system that powers Emerson’s PlantWeb digital plant architecture. Continuous on-line diagnostics deliver predictive intelligence to help simplify validation and enable predictive maintenance. Sanitary conductivity product reportedly ensures CIP sanitizing without wasting chemicals, effectively monitoring cleaning solution strength because conductivity provides a direct correlation to concentration. Sensor offers a wide conductivity range from 200
Interphex 2006 marks the 27th annual running of the pharmaceutical manufacturing conference and exhibition. Nearly 1,000 companies showcased products at the event, which ran Mar. 21-23. In addition to the exhibition and technical conferences, Interphex recognized emerging leaders in pharmaceutical science and technology for the first time.
Honored were Sandy Cope, senior scientist, AstraZeneca Pharmaceuticals, Wilmington, DE; Derek Y. P. Ung, senior biopharmaceutical facility design engineer, Johnson & Johnson, New Brunswick, NJ; and D. Christopher Watts, staff fellow, Food and Drug Administration Center for Drug Evaluation and Research, Silver Spring, MD. Called GenerationNext , the program awards young professionals (35 years or younger) who have shown exceptional ability to lead, bring constructive change, and maintain excellence in their work on the technical, scientific, and regulatory aspects of pharmaceutical manufacturing.